Precision follow-up study for osteoporosis treatment
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study is a follow-up for people who completed a previous precision medicine trial for osteoporosis. It will monitor your bone health to see how well the treatment is working over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with osteoporosis (a bone-thinning condition) based on a DXA scan with a T-score of -2.5 or lower, with or without a history of broken bones from minor falls.
- You were in the previous 'Novel precision medicine approach to treatment of osteoporosis' trial and finished the therapy part.
- You are a woman who is premenopausal, menopausal, or postmenopausal, and you are 45 years or older.
- Your Vitamin D levels are normal (at least 20 ng/mL).
- You do not have any of the listed health conditions or situations that would exclude you, such as pregnancy, blood thinners, recent cancer history, or certain other bone diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to help adults over 50 who had a recent bone fracture (from a minor fall) get better follow-up care to prevent future fractures. You will work with a nurse or coordinator to connect with your primary care doctor and learn about bone health options.
This trial studies AGN1 LOEP, a treatment being tested to improve bone strength in people with osteoporosis-related bone loss in the hip. If you qualify, you would be followed over time with clinic visits and testing to see how the treatment affects your bone health.
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
This study looks at ways to prevent and treat “brittle bone” refractures after a recent fracture in people with osteoporosis. If you’ve had a new hip, spine, or other bone fracture, the trial may test strategies to lower the chance of another fracture.
This trial tests teriparatide (a hormone-like bone medicine) to improve bone health in people with advanced chronic kidney disease who are at risk for weak, low-turnover bone. It may help by changing how quickly your bones break down and rebuild.
This trial looks at a personalized approach to diagnosing and treating bone problems caused by long-term kidney disease. It may help by matching treatment plans to the type of bone turnover found in your tests or biopsy.
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.